Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer

Clinical trial NCT07379476 · RECRUITING

Trial details

NCT number: NCT07379476
Sponsor: Chinese University of Hong Kong
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)

Start date: 2026-02-11
Primary completion: 2029-03-03
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.